Seres Therapeutics (MCRB) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for Seres Therapeutics (MCRB) over the last 10 years, with Q3 2025 value amounting to $618000.0.
- Seres Therapeutics' Interest & Investment Income fell 521.47% to $618000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 5966.19%. This contributed to the annual value of $4.0 million for FY2024, which is 4566.5% down from last year.
- As of Q3 2025, Seres Therapeutics' Interest & Investment Income stood at $618000.0, which was down 521.47% from $546000.0 recorded in Q2 2025.
- In the past 5 years, Seres Therapeutics' Interest & Investment Income ranged from a high of $2.6 million in Q3 2023 and a low of $384000.0 during Q1 2022
- For the 5-year period, Seres Therapeutics' Interest & Investment Income averaged around $998842.1, with its median value being $829000.0 (2021).
- In the last 5 years, Seres Therapeutics' Interest & Investment Income surged by 102027.03% in 2021 and then tumbled by 7782.85% in 2024.
- Quarter analysis of 5 years shows Seres Therapeutics' Interest & Investment Income stood at $485000.0 in 2021, then skyrocketed by 191.55% to $1.4 million in 2022, then skyrocketed by 39.39% to $2.0 million in 2023, then plummeted by 77.83% to $437000.0 in 2024, then skyrocketed by 41.42% to $618000.0 in 2025.
- Its Interest & Investment Income stands at $618000.0 for Q3 2025, versus $546000.0 for Q2 2025 and $618000.0 for Q1 2025.